Chardan Capital Trims PT on Esperion (ESPR) Following Q2 Results, TAK-475 Failure Concerning for ETC-1002

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. SPY
3. FDX
4. META
5. ABBV
6. ACN
7. BLZE
8. IBM
9. NKE
10. MU

Go back to Chardan Capital Trims PT on Esperion (ESPR) Following Q2 Results, TAK-475 Failure Concerning for ETC-1002

Form 8-K Esperion Therapeutics, For: Aug 06

August 6, 2015 4:17 PM EDT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

... More